Catalyzing Ontario’s Life Sciences Economy: Urgent Call to Bridge the Risk Capital Gap
Ontario’s life sciences sector is a global leader in research and talent—but a critical shortage of seed-stage capital is limiting its ability to commercialize innovation and retain homegrown companies. A new report from Life Sciences Ontario and Shift Health outlines the urgency of this challenge and presents a clear roadmap for change.
Policy Brief—Breaking Barriers: Expanding CAR T Access in Canada
Recognizing the potential for CAR T to transform the way we treat some of the most complex conditions, Shift Health assembled a multidisciplinary panel of experts to develop concrete recommendations to prepare Canadian healthcare systems to enhance equitable access to this innovative treatment.
Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries
This peer-reviewed paper presents solutions to alleviate health system capacity constraints for retinal care.
Measuring the Impact of Research
Impact assessments help funders and health research organizations evaluate progress and performance of their investments and optimize plans for long-term success.
Status of Inclusion, Diversity, Equity and Accessibility (IDEA) in Canada’s Life Sciences Sector
The report is informed by the findings from a national survey of life sciences organizations and focus groups with diverse individuals working in the sector.
Curating the Cabinet
We share key insights for pharmaceutical companies bringing new products to the Canadian market, highlighting considerations for the current and future hospital formulary decision-making landscape.